Graham G - Search Results

1

Population pharmacokinetics and optimal design of paediatric studies for famciclovir.

Ogungbenro K, Matthews I, Looby M, Kaiser G, Graham G, Aarons L. Ogungbenro K, et al. Among authors: graham g. Br J Clin Pharmacol. 2009 Oct;68(4):546-60. doi: 10.1111/j.1365-2125.2009.03479.x. Br J Clin Pharmacol. 2009. PMID: 19843058 Free PMC article.

2

Optimal design for multiresponse pharmacokinetic-pharmacodynamic models - dealing with unbalanced designs.

Ogungbenro K, Gueorguieva I, Majid O, Graham G, Aarons L. Ogungbenro K, et al. Among authors: graham g. J Pharmacokinet Pharmacodyn. 2007 Jun;34(3):313-31. doi: 10.1007/s10928-006-9048-7. Epub 2007 Feb 7. J Pharmacokinet Pharmacodyn. 2007. PMID: 17285361

3

Incorporating correlation in interindividual variability for the optimal design of multiresponse pharmacokinetic experiments.

Ogungbenro K, Graham G, Gueorguieva I, Aarons L. Ogungbenro K, et al. Among authors: graham g. J Biopharm Stat. 2008;18(2):342-58. doi: 10.1080/10543400701697208. J Biopharm Stat. 2008. PMID: 18327725

4

Determination of an optimal dosage regimen using a Bayesian decision analysis of efficacy and adverse effect data.

Graham G, Gupta S, Aarons L. Graham G, et al. J Pharmacokinet Pharmacodyn. 2002 Feb;29(1):67-88. doi: 10.1023/a:1015720718875. J Pharmacokinet Pharmacodyn. 2002. PMID: 12194536

5

The use of a modified Fedorov exchange algorithm to optimise sampling times for population pharmacokinetic experiments.

Ogungbenro K, Graham G, Gueorguieva I, Aarons L. Ogungbenro K, et al. Among authors: graham g. Comput Methods Programs Biomed. 2005 Nov;80(2):115-25. doi: 10.1016/j.cmpb.2005.07.001. Epub 2005 Aug 31. Comput Methods Programs Biomed. 2005. PMID: 16139390

6

Sample size calculations based on generalized estimating equations for population pharmacokinetic experiments.

Ogungbenro K, Aarons L, Graham G. Ogungbenro K, et al. Among authors: graham g. J Biopharm Stat. 2006;16(2):135-50. doi: 10.1080/10543400500508705. J Biopharm Stat. 2006. PMID: 16584063

7

A program for individual and population optimal design for univariate and multivariate response pharmacokinetic-pharmacodynamic models.

Gueorguieva I, Ogungbenro K, Graham G, Glatt S, Aarons L. Gueorguieva I, et al. Among authors: graham g. Comput Methods Programs Biomed. 2007 Apr;86(1):51-61. doi: 10.1016/j.cmpb.2007.01.004. Epub 2007 Feb 9. Comput Methods Programs Biomed. 2007. PMID: 17292995

8

Methodological approaches to the population analysis of toxicity data.

Aarons L, Graham G. Aarons L, et al. Among authors: graham g. Toxicol Lett. 2001 Mar 31;120(1-3):405-10. doi: 10.1016/s0378-4274(01)00272-7. Toxicol Lett. 2001. PMID: 11323200

9

Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan.

Nestorov I, Graham G, Duffull S, Aarons L, Fuseau E, Coates P. Nestorov I, et al. Among authors: graham g. Pharm Res. 2001 Aug;18(8):1210-9. doi: 10.1023/a:1010943430471. Pharm Res. 2001. PMID: 11587494

10

Optimum blood sampling time windows for parameter estimation in population pharmacokinetic experiments.

Graham G, Aarons L. Graham G, et al. Stat Med. 2006 Dec 15;25(23):4004-19. doi: 10.1002/sim.2512. Stat Med. 2006. PMID: 16463254

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,363 results

Search Page

Filters